Paper9770530
Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.
Lou XJ and 4 others. Proc Natl Acad Sci U S A, 1998. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice. Papers, record 9770530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9770530
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Afibrinogenemia | Major topic |
| Aorta | Major topic |
| Apolipoproteins | Major topic |
| Arteriosclerosis | Major topic |
| Lipoprotein(a) | Major topic |
| Animals | |
| Apoprotein(a) | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Transgenic |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL-47826 | NHLBI NIH HHS | United States | R01HL047826 | PubMed and NIH | NIH RePORTER |
| HL-50590 | NHLBI NIH HHS | United States | R01HL050590 | PubMed and NIH | NIH RePORTER |
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3426656 | Quantitative assessment of atherosclerotic lesions in mice. | Atherosclerosis | 1987 | https://conductscience.org/library/papers/3426656 | PubMed |
| 2 | 9486990 | Fibrinogen deficiency is compatible with the development of atherosclerosis in mice. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9486990 | PubMed |
| 3 | 2524666 | Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. | Nature | 1989 | https://conductscience.org/library/papers/2524666 | PubMed |
| 4 | 2543441 | Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site. | Biochemistry | 1989 | https://conductscience.org/library/papers/2543441 | PubMed |
| 5 | 2530631 | The mysteries of lipoprotein(a). | Science | 1989 | https://conductscience.org/library/papers/2530631 | PubMed |
| 6 | 2137266 | Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator. | Thromb Res | 1990 | https://conductscience.org/library/papers/2137266 | PubMed |
| 7 | 2138452 | Lipoprotein(a), fibrin binding, and plasminogen activation. | Arteriosclerosis | 1990 | https://conductscience.org/library/papers/2138452 | PubMed |
| 8 | 2317166 | Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. | Arteriosclerosis | 1990 | https://conductscience.org/library/papers/2317166 | PubMed |
| 9 | 2140835 | Lipoprotein (a). Heterogeneity and biological relevance. | J Clin Invest | 1990 | https://conductscience.org/library/papers/2140835 | PubMed |
| 10 | 2169655 | Lp(a): an interloper into the fibrinolytic system? | Thromb Haemost | 1990 | https://conductscience.org/library/papers/2169655 | PubMed |
| 11 | 1848551 | Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1848551 | PubMed |
| 12 | 1830206 | Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects. | Atherosclerosis | 1991 | https://conductscience.org/library/papers/1830206 | PubMed |
| 13 | 1910153 | Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. | Nature | 1991 | https://conductscience.org/library/papers/1910153 | PubMed |
| 14 | 1280258 | Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). | J Biol Chem | 1992 | https://conductscience.org/library/papers/1280258 | PubMed |
| 15 | 1465128 | Atherogenesis in transgenic mice expressing human apolipoprotein(a) | Nature | 1992 | https://conductscience.org/library/papers/1465128 | PubMed |
| 16 | 8100742 | Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. | Cell | 1993 | https://conductscience.org/library/papers/8100742 | PubMed |
| 17 | 7507326 | Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques. | Atherosclerosis | 1993 | https://conductscience.org/library/papers/7507326 | PubMed |
| 18 | 8047165 | Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. | Nature | 1994 | https://conductscience.org/library/papers/8047165 | PubMed |
| 19 | 7695189 | Fibrinogen in human atherosclerosis. | Ann N Y Acad Sci | 1995 | https://conductscience.org/library/papers/7695189 | PubMed |
| 20 | 7705657 | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | Genes Dev | 1995 | https://conductscience.org/library/papers/7705657 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42490834 | Rather a versatile multi-tool than a sword: an integral role of the plasminogen system in health and disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42490834 | PubMed |
| 36798900 | Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: a case-control study in Iran. | Res Pract Thromb Haemost | 2023 | https://conductscience.org/library/papers/36798900 | PubMed |
| 34849696 | Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. | Eur Heart J | 2022 | https://conductscience.org/library/papers/34849696 | PubMed |
| 32931586 | Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment. | Cardiovasc Res | 2021 | https://conductscience.org/library/papers/32931586 | PubMed |
| 30580574 | Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases. | Arterioscler Thromb Vasc Biol | 2019 | https://conductscience.org/library/papers/30580574 | PubMed |
| 27205885 | Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. | Curr Opin Cardiol | 2016 | https://conductscience.org/library/papers/27205885 | PubMed |
| 23040268 | Lipoprotein(a) metabolism: potential sites for therapeutic targets. | Metabolism | 2013 | https://conductscience.org/library/papers/23040268 | PubMed |
| 19693531 | Fibulin-1 and fibrinogen in human atherosclerotic lesions. | Histochem Cell Biol | 2009 | https://conductscience.org/library/papers/19693531 | PubMed |
| 15574198 | Blood coagulation and the risk of atherothrombosis: a complex relationship. | Thromb J | 2004 | https://conductscience.org/library/papers/15574198 | PubMed |
| 12629066 | Fibrin-mediated protection against infection-stimulated immunopathology. | J Exp Med | 2003 | https://conductscience.org/library/papers/12629066 | PubMed |
| 11073835 | Genetic modifiers of atherosclerosis in mice. | Arterioscler Thromb Vasc Biol | 2000 | https://conductscience.org/library/papers/11073835 | PubMed |
| 11056680 | Enhanced expression of genes involved in coagulation and fibrinolysis in murine arthritis. | Arthritis Res | 2000 | https://conductscience.org/library/papers/11056680 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9770530
GET https://conductscience.org/api/papers/v1/9770530/references?page=2